FERRARI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 6.627
AS - Asia 5.183
EU - Europa 3.545
SA - Sud America 818
AF - Africa 129
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.308
Nazione #
US - Stati Uniti d'America 6.309
VN - Vietnam 1.556
SG - Singapore 1.340
IT - Italia 1.293
CN - Cina 1.055
BR - Brasile 610
HK - Hong Kong 530
DE - Germania 445
RU - Federazione Russa 406
CA - Canada 246
SE - Svezia 205
IE - Irlanda 200
GB - Regno Unito 199
FR - Francia 170
BD - Bangladesh 132
IN - India 130
FI - Finlandia 96
UA - Ucraina 96
NL - Olanda 79
ID - Indonesia 78
AR - Argentina 76
KR - Corea 70
AT - Austria 68
DK - Danimarca 64
ES - Italia 60
ZA - Sudafrica 53
MX - Messico 47
TR - Turchia 47
PL - Polonia 43
IQ - Iraq 40
CO - Colombia 37
JP - Giappone 28
PK - Pakistan 28
VE - Venezuela 27
PH - Filippine 25
SA - Arabia Saudita 24
CH - Svizzera 23
EC - Ecuador 22
BE - Belgio 18
CL - Cile 18
CZ - Repubblica Ceca 17
LT - Lituania 16
MA - Marocco 16
UZ - Uzbekistan 16
TN - Tunisia 13
JO - Giordania 12
PY - Paraguay 11
ET - Etiopia 10
IL - Israele 9
IR - Iran 9
KE - Kenya 9
PE - Perù 9
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
EG - Egitto 7
KZ - Kazakistan 7
MY - Malesia 7
AL - Albania 6
GR - Grecia 6
JM - Giamaica 6
NP - Nepal 6
PT - Portogallo 6
RS - Serbia 6
BO - Bolivia 5
TT - Trinidad e Tobago 5
AU - Australia 4
AZ - Azerbaigian 4
BG - Bulgaria 4
NO - Norvegia 4
PA - Panama 4
CY - Cipro 3
DO - Repubblica Dominicana 3
OM - Oman 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
UY - Uruguay 3
BY - Bielorussia 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
LV - Lettonia 2
LY - Libia 2
NG - Nigeria 2
SI - Slovenia 2
YE - Yemen 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BZ - Belize 1
CR - Costa Rica 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
Totale 16.296
Città #
Ann Arbor 961
Singapore 771
Ashburn 664
Hong Kong 519
Ho Chi Minh City 448
Hanoi 429
Fairfield 408
Milan 403
San Jose 403
Frankfurt am Main 287
Woodbridge 273
Wilmington 248
Dallas 239
Houston 210
Chandler 199
Dublin 192
New York 182
Seattle 168
Toronto 165
Cambridge 144
Beijing 143
Hefei 135
Los Angeles 132
Santa Clara 121
Chicago 106
Dearborn 93
Rome 86
Jacksonville 82
Council Bluffs 72
Shanghai 70
The Dalles 70
Princeton 69
Dong Ket 64
Seoul 62
Lauterbourg 61
São Paulo 61
Buffalo 58
Jakarta 55
Vienna 52
Haiphong 50
Helsinki 50
Nanjing 49
Moscow 43
Da Nang 41
Guangzhou 36
Warsaw 35
Lawrence 34
Munich 34
Quận Bình Thạnh 33
Montreal 32
Johannesburg 31
London 29
Biên Hòa 27
Hyderabad 27
San Diego 26
Altamura 25
Orem 25
Boardman 24
Denver 24
Hải Dương 24
Atlanta 23
Poplar 23
Rio de Janeiro 22
Nuremberg 21
Zurich 21
Columbus 20
Turin 20
Newark 19
Turku 19
Amsterdam 17
Can Tho 17
Ha Long 17
Nanchang 17
Shenyang 17
Thái Nguyên 17
Baghdad 16
Bologna 16
Brussels 16
Mexico City 16
Tokyo 16
Changsha 15
Dhaka 15
Piscataway 15
San Francisco 15
Washington 15
Andover 14
Brooklyn 14
Genoa 14
Kent 14
Phoenix 14
Stockholm 14
Tashkent 14
Vũng Tàu 14
Bari 13
Brno 13
Chennai 13
Lachine 13
Lang Son 13
Lappeenranta 13
Messina 13
Totale 10.252
Nome #
Preliminary data of ICV delivery of human Neural Stem Cells in a mouse model of Amyotrophic Lateral Sclerosis 1.145
Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation 794
Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats 391
Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome 383
Human neural stem cell transplantation in ALS: Initial results from a phase I trial 345
Mitochondrial and energy metabolism dysfunctions are hallmarks of TDP-43G376D fibroblasts from members of an Amyotrophic Lateral Sclerosis family 334
Morphological and metabolic changes in microglia exposed to cadmium: Cues on neurotoxic mechanisms 322
Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients 316
A link between genetic disorders and cellular impairment, using human induced pluripotent stem cells to reveal the functional consequences of copy number variations in the central nervous system—a close look at chromosome 15 309
Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis 308
Immortalization of human neural stem cells with the c-myc mutant T58A 305
Production and characterization of human induced pluripotent stem cells (iPSC) CSSi007-A (4383) from Joubert Syndrome 305
Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies 292
Mild hypoxia enhances proliferation and multipotency of human neural stem cells 291
Intravenous neural stem cells abolish nociceptive hypersensitivity and trigger nerve regeneration in experimental neuropathy 279
Generation of induced pluripotent stem cell line, CSSi002-A (2851), from a patient with juvenile Huntington Disease 274
Generation and characterization of a patient-derived iPSC line, CSSi022-A (15666), with a pathogenic MFN2 mutation causing Charcot-Marie-Tooth disease type 2A 270
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 269
Neural stem cells and human induced pluripotent stem cells to model rare CNS diseases 262
Retrieval of germinal zone neural stem cells from the cerebrospinal fluid of premature infants with intraventricular hemorrhage 262
Recent therapeutic advances in the treatment and management of amyotrophic lateral sclerosis: the era of regenerative medicine 261
Preliminary data of intracerebroventricular transplantation of human-Neural Stem Cells in a mouse model of Amyotrophic Lateral Sclerosis 260
Generation of induced pluripotent stem cells (CSSi017-A)(12862) from an ALS patient carrying a repeat expansion in the C9orf72 gene 256
Adult stem cell as new advanced therapy for experimental neuropathic pain treatment 254
Production and characterization of human induced pluripotent stem cells (iPSCs) from Joubert Syndrome: CSSi001-A (2850) 254
Generation of induced pluripotent stem cell line CSSi008-A (4698) from a patient affected by advanced stage of Dentato-Rubral-Pallidoluysian atrophy (DRPLA) 254
Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice. 250
Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (Cyno-1) after transplantation 247
Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage 247
Production of CSSi013-A (9360) iPSC line from an asymptomatic subject carrying an heterozygous mutation in TDP-43 protein 247
Induced pluripotent stem cell production (CSSi019-A)(14432) from an asymptomatic subject carrying a expansion of C9orf72 gene 244
Human Fetal Neural Stem Cells for Neurodegenerative Disease Treatment 243
Generation of an induced pluripotent stem cell line (CSS012-A (7672)) carrying the p.G376D heterozygous mutation in the TARDBP protein 243
Differential pathotropism of non-immortalized and immortalized human neural stem cell lines in a focal demyelination model 242
Isolation of neural stem cells from neural tissues using the neurosphere technique 241
Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease 241
Long-term survival of human neural stem cells in the ischemic rat brain upon transient immunosuppression 240
Unique expression and localization of aquaporin-4 and aquaporin-9 in murine and human neural stem cells and in their glial progeny 235
Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization 227
Generation of an induced pluripotent stem cells line, CSSi014-A 9407, carrying the variant c.479C>T in the human iduronate 2-sulfatase (hIDS) gene 223
Advances in stem cell therapy for amyotrophic lateral sclerosis 222
Production and characterization of CSSI003 (2961) human induced pluripotent stem cells (iPSCs) carrying a novel puntiform mutation in RAI1 gene, Causative of Smithâ Magenis syndrome 219
Exploring the metabolic signature of ALS patients-derived cells 214
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis 213
Production of an induced pluripotent stem cell line CSSi018-A (14192) from a patient with hypomyelinating leukodystrophy 7 (HLD7) carrying biallelic variants of POLR3A (c.1802 T > A; c.4072G > A) 209
Generation of the CSSi020-A (14437) iPSC line from a patient carrying a copy number variation (CNV) in the 17p11.2 chromosome region 206
Copy number variations in healthy subjects. Case study: iPSC line CSSi005-A (3544) production from an individual with variation in 15q13.3 chromosome duplicating gene CHRNA7 204
Generation of an induced pluripotent stem cell line CSSi015-A (9553), carrying a point mutation c.2915C > T in the human calcium sensing receptor (CasR) gene 203
Retinoic acid-induced 1 gene haploinsufficiency alters lipid metabolism and causes autophagy defects in Smith-Magenis syndrome 203
Exploring the metabolic signature of Amyotrophic Lateral Sclerosis patients-derived cells 202
Functional outcomes of copy number variations of Chrna7 gene: Current knowledge and new insight from induced pluripotent stem cells studies 196
Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft 194
Inorganic mercury changes the fate of murine CNS stem cells 187
Generation and characterization of the CSSi021-A (15665) human induced pluripotent stem cell line from a Smith-Magenis syndrome patient with a heterozygous RAI1 mutation 182
Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage Juvenile Onset Huntington's Disease 180
Safety and efficacy evaluation of intracerebroventricular human neural stem cell transplantation in SOD1 mice as a novel approach for ALS 173
The stem cells as a potential treatment for neurodegeneration 171
Culturing and Expansion of “Clinical Grade” Neural Stem Cells from the Fetal Human Central Nervous System 171
Unraveling the impact of human cerebrospinal fluid on human neural stem cell fate 170
INTERROGATING ALS SIGNATURE IN HUMAN INDUCED NEURAL STEM CELLS 155
INTERROGATING ALS SIGNATURE IN EARLY NEURAL PROGENITOR CELLS: A DIFFERENT PERSPECTIVE 144
Brain Organoids to Evaluate Cellular Therapies 137
Uncovering primary cilium defects in Joubert Syndrome using iPSCs derived-Neural Stem Cells 122
Traffic-related diesel pollution particles impair the lysosomal functions of human iPSC-derived microglia 86
Totale 16.728
Categoria #
all - tutte 48.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.051


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021174 0 0 0 0 0 0 0 0 0 0 0 174
2021/2022607 63 82 75 27 20 40 48 72 30 27 58 65
2022/20231.057 89 269 139 111 93 147 10 51 58 23 39 28
2023/2024909 26 29 56 73 103 188 148 42 68 35 32 109
2024/20253.666 126 195 242 138 183 123 156 110 302 430 251 1.410
2025/20266.862 669 680 547 817 763 357 852 318 588 678 368 225
Totale 16.728